INtRODUCtION
Breast cancer is the commonest female cancer in Hong Kong since the early 1990s. It is the third leading cause of death among all women with cancer in Hong Kong. There has been a rising incidence of breast cancer over the past 20 years, not only in the western population but also in the Chinese population. The incidence has tripled from 1993 to 2011. 1, 2 Currently, there is no population-based breast screening programme in Hong Kong, while there are established breast screening programmes in the United States, United Kingdom, Singapore, and Japan among others. There is increasing public awareness of breast cancer worldwide and more women are now performing selfbreast examination. A growing number of women are attending the breast clinic for self-examined breast masses.
The American College of Radiology recommends that ultrasound can be considered an adjunct to screening mammography in women with dense breast tissue or in high-risk women for whom magnetic resonance imaging (MRI) cannot be done. 3 However, there is no consensus on the usefulness of ultrasound screening in the Asian population. Several studies also observe that Asians or Chinese generally have denser breast tissue. 4, 5 Ultrasound is a well-tolerated, inexpensive, and widely available modality compared with mammography and MRI. In many centres, ultrasound screening of both breasts is done in addition to mammography. However, some centres only perform targeted ultrasound. At Tuen Mun Hospital in Hong Kong, symptomatic patients attend the new case breast clinic and are referred to the radiology department for imaging. Patients older than 40 years have mammogram and ultrasound scan performed, whereas patients younger than 40 years only have ultrasound scan. All new cases also have bilateral whole-breast ultrasound scans.
The purpose of this study was to evaluate the characteristics and clinical outcome of non-palpable breast lesions screened by ultrasound scan.
MEtHODS
From January 2011 to June 2011, all new cases referred to the breast clinic at Tuen Mun Hospital were identified. Using the hospital's electronic patient records, all clinical notes at the breast clinic were reviewed. Baseline patient demographics, including age and family history of breast cancer, were documented. The presenting symptoms, such as a palpable mass, lumpiness or nipple discharge, were recorded. If patients had mammogram done, whether or not any mass was identified was noted. Ultrasound was performed by radiologists with at least 5 years of experience in ultrasound imaging. The images were reviewed by two radiologists, one of whom had completed training in breast radiology and the other was a breast radiology trainee. Images were assessed on the hospital's picture archiving and communication
system. All lesions identified on ultrasound, whether palpable or not, were documented and lesion characteristics, including the maximum dimension up to two decimal places and Breast Imaging Reporting and Data System (BI-RADS) classification, were analysed.
Inclusion and Exclusion Criteria
The inclusion criteria were palpable masses or mammographically detected breast masses (control group) and asymptomatic non-palpable breast masses detected incidentally on ultrasound only (investigation group). Only female patients were recruited. Patients who had previous private imaging were excluded since their ultrasound studies could not be accessed and evaluated. Patients with only targeted ultrasound done or inadequate follow-up time were also excluded.
The nature of the lesions was confirmed with tissue diagnosis, either cytology from fine-needle aspiration or histology from core biopsy. Benignity was defined by the tissue diagnosis result or presumed after at least 2 years of follow-up with no change or a decrease in the size of the lesion.
Statistical Analysis
This was a retrospective cross-sectional study. The chi-square test was used to calculate any statistical differences between the outcomes in the two groups. The independent t-test was used to calculate any statistical differences in the size of the lesions between the two groups. The BI-RADS classification was arranged into BI-RADS 2/3 and BI-RADS 4/5 for categorical analysis. The chi-square test was used to calculate the statistical difference in BI-RADS classification between the control group and investigation group.
RESUltS
A total of 689 patients attended the new case breast clinic at Tuen Mun Hospital, Hong Kong from January 2011 to June 2011 and 493 patients were excluded from the study. There were 196 patients with 426 lesions identified. Among the 426 lesions were 130 palpable or mammographically detected lesions (control group) and 296 non-palpable ultrasound-detected lesions; of the latter group, four non-palpable lesions in the contralateral breast of patients with palpable breast cancers were excluded, making 292 as the total number of lesions in the investigation group (Figure) .
The baseline patient characteristics in both groups were comparable. The mean age was 44 years in the control group and 42 years in the investigation group. There were 10 (7.7%) and 8 (2.7%) patients with a family history of breast cancer in the control group and investigation group, respectively.
Of the patients studied, 133 (67.9%) patients presented with masses, 33 (16.8%) with lumpiness, 54 (27.6%) with mastalgia, 41 (20.9%) with nipple discharge, and other reasons included screening of those with a family history of breast cancer. Some patients had two or more symptoms at the same time.
The maximum dimension of the lesion was significantly smaller in the investigation group (p < 0.05). The mean size was 2.32 cm in the control group and 0.91 cm in the investigation group (Table) . The BI-RADS classification was significantly lower in the investigation group (p < 0.05). Most of the lesions in both groups were BI-RADS 3.
There were 156 lesions with tissue diagnosis and 270 lesions were followed up for at least 2 years with no change or a decrease in size, indicating benignity. In the control group, 18 (13.8%) lesions were malignant while, in the investigation group, no lesions were malignant (p < 0.05) [ Table] . Incidental lesions detected in the contralateral breast of the 18 patients with palpable breast cancers were excluded from the investigation group to eliminate possible high-risk patients but there was still a statistically significant difference between the two groups (p < 0.05).
Two patients had non-palpable ultrasound-detected lesions with a tissue diagnosis of atypical cells showing no change in size after 2 years. One patient had atypical ductal hyperplasia and subsequently underwent surgical excision.
DISCUSSION
According to the American College of Radiology, ultrasound can be considered an adjunct to screening mammography in women with dense breast tissue or in high-risk women for whom MRI cannot be done. 3 In the United Kingdom, mammography remains the gold standard of the National Health Service Breast Screening Programme and the use of ultrasound is not addressed. 6 The Singapore national breast cancer screening programme, BreastScreen Singapore, only uses ultrasound as an additional test, depending on the mammography result. 7 There is still much debate on the usefulness of ultrasound screening, whether it can be used alone or must only be considered an adjunct to mammography in the Asian population. 2, 8 In Hong Kong, many public and private institutions still advocate ultrasound screening of both breasts rather than targeted ultrasound.
Ultrasound is a well-tolerated, cost-effective, and widely available modality, which may be an attractive alternative to mammography if women are given the option. Some Asian women have smaller breast volume and compression of the breast may be a highly uncomfortable experience, so ultrasound screening, being less traumatic, may be more favourable in this population. 9 In addition, many Chinese women may have denser breast tissue 4,5 so interpretation of the mammograms can be quite challenging. Many studies concentrate on the usefulness of mammography and MRI, but few studies address the usefulness of ultrasound in Asian or Chinese populations. Therefore, this study explored the effectiveness of ultrasound screening in Asian women.
Our study concludes that ultrasound can easily detect non-palpable lesions as small as 0.20 cm. This result suggests that ultrasound is a good investigation modality for identifying occult masses, especially in young patients or patients who have denser background breast tissue as proposed in many previous studies. [10] [11] [12] [13] [14] [15] [16] [17] With increasing breast density, the sensitivity of mammography decreases. Therefore, in Asian women with generally smaller denser breasts, ultrasound is likely to better detect small occult lesions than mammography. However, this needs to be balanced with possible increases in cost, biopsy rates, and patient anxiety. 2, 8, 17, 18 Our results also suggest that the BI-RADS classification and tissue diagnosis of incidental lesions are more likely to be benign (p < 0.05). Most of the lesions in both groups were BI-RADS 3. This outcome is in line with current guidelines and studies that screening ultrasound is limited by a low positive predictive value with a higher number of false positives when compared with screening mammography. [15] [16] [17] [18] [19] In our study, screening ultrasound also detected two atypical lesions and one atypical ductal hyperplasia, which affected the management. Although no breast cancers were detected, ultrasound may still be useful in certain high-risk groups to detect premalignant lesions. There is limited literature on the assessment of ultrasound to identify premalignant lesions; further local studies in this area can be considered.
There are a few limitations to this study. First, this is a retrospective single-centre study in patients who were initially symptomatic, therefore in a diagnostic group. However, we postulate that if the lesions were non-palpable and incidentally detected on ultrasound, then the lesions are likely to be similar to those in a screening population. We also excluded many patients who had previously undergone imaging in private practice, only had targeted ultrasound, or had no tissue diagnosis with inadequate follow-up, which compromises the sample size. Second, ultrasound is operator-dependent, therefore the accuracy and quality of the images taken are unknown factors. In our study, ultrasound was performed by radiologists with at least 5 years of experience in ultrasound imaging. Lastly, cytology from fine-needle aspiration may not be adequate for accurate diagnosis and the interpretation relies heavily on the confidence and experience of the pathologist. However, many women opt for fineneedle aspiration as a less invasive procedure before considering core biopsy. If further studies are to be done, perhaps only core biopsy results should be included. For patients without tissue diagnosis, 2 yearsʼ follow-up should be adequate.
CONClUSION
Ultrasound is a useful tool to detect small lesions, which are mammographically occult and non-palpable. However, these lesions are inclined to be more benign looking (BI-RADS 2/3) and pathologically benign. Ultrasound may also incidentally detect premalignant lesions such as atypical ductal hyperplasia; therefore further studies, for example in high-risk patients, are worth exploring.
